Cognetivity Neurosciences Ltd. announced a collaboration with the Mediclinic Group. This pivotal partnership will start in the United Arab Emirates and is set to revolutionize brain health diagnosis and care in the region, effectively addressing the escalating concern around Alzheimer's disease and other cognitive health issues. Under this commercial engagement, Cognetivity's cognitive assessment platform, CognICA, will be seamlessly integrated into Mediclinic's healthcare services.

CognICA harnesses the power of artificial intelligence (AI) and machine learning to deliver rapid, accurate, and non-invasive cognitive assessments, allowing accurate, early detection of brain health issues. This strategic partnership underscores the commitment of both Cognetivity and Mediclinic to take a proactive stance against the rising challenges around brain health. The collaboration will roll out in a phased approach, commencing with the inclusion of CognICA into Mediclinic's Healthy Aging Program.

This initial phase empowers family medicine doctors, geriatricians, and neurologists across select clinics and hospitals to conduct cognitive screenings on individuals aged 50 and above. By identifying cognitive impairments early on, interventions are much more effective, and this initiative aligns with Mediclinic's dedication to preventative care, promoting optimal patient well- being and quality of life. As the engagement progresses, CognICA will further enhance Mediclinic's Cognitive Diagnostic Pathway, facilitating precise evaluations and tailored recommendations by neurologists.

Additionally, the partnership will extend to the clinical services of Park View Hospital, expanding the reach of cognitive screening and monitoring to a diverse patient population and improving patient outcomes in this rapidly growing at-risk group. This strategic partnership represents a significant step toward addressing the growing challenge of cognitive health disorders in the UAE, emphasizing the commitment of both organizations to improving patient outcomes and overall quality of life. Cognetivity Neurosciences' mission is to utilize its AI platform technology to transform the landscape of brain health globally, enhance the quality of care provided to patients and to reduce the burden and cost to providers and payers, delivering the company's vision of A Brighter Mind for a Fuller Life.